Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging infectious diseases 2021-10, Vol.27 (10), p.2662-2665
Hauptverfasser: Tinker, Sarah C, Szablewski, Christine M, Litvintseva, Anastasia P, Drenzek, Cherie, Voccio, Gary E, Hunter, Melissa A, Briggs, Stephen, Heida, Debbie E, Folster, Jennifer, Shewmaker, Patricia L, Medrzycki, Magdalena, Bowen, Michael D, Bohannon, Caitlin, Bagarozzi, Dennis, Jr, Petway, Marla, Rota, Paul A, Kuhnert-Tallman, Wendi, Thornburg, Natalie, Prince-Guerra, Jessica L, Barrios, Lisa C, Tamin, Azaibi, Harcourt, Jennifer L, Honein, Margaret A
Format: Artikel
Sprache:eng
Schlagworte:
adolescents
antigen testing
Antigens
Asymptomatic
College students
Coronaviruses
COVID-19
Developmental disabilities
Disease control
Disease prevention
Disease transmission
Dispatch
Health aspects
Influenza
institutions of higher education
Laboratories
Medical examination
Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students
Public health
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Teenagers
Viruses
Young adults
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity was 60%. BinaxNOW provides point-of-care screening but misses many infections.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2710.210080